HCPCS Codes - Medical Procedures, Supplies & DME Codes - j7 Codes
HCPCS Procedure, Supply & DME (Durable Medical Equipment) Codes ("j7" Codes):- J7030 infusion normal saline solution 1000 HCPCS Code Code
- J7040 infusion normal saline solution sterile 500 HCPCS Code Code
- J7042 5 dextrosenormal saline 500 ml HCPCS Code Code
- J7050 infusion normal saline solution 250 HCPCS Code Code
- J7051 STERILE SALINE/WATER HCPCS Code Code
- J7060 5 dextrosewater 500 ml 1 HCPCS Code Code
- J7070 infusion d5w 1000 cc HCPCS Code Code
- J7100 infusion dextran 40 500 ml HCPCS Code Code
- J7110 infusion dextran 75 500 ml HCPCS Code Code
- J7120 ringers lactate infusion up 1000 cc HCPCS Code Code
- J7121 5% dextrose in lactated ringers infusion, up HCPCS Code Code
- J7130 hypertonic saline solution 50 100 meq HCPCS Code Code
- J7131 Hypertonic saline solution, 1 ml HCPCS Code Code
- J7165 Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity HCPCS Code Code
- J7168 Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity HCPCS Code Code
- J7169 Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg HCPCS Code Code
- J7170 Injection, emicizumab-kxwh, 0.5 mg HCPCS Code Code
- J7171 Injection, adamts13, recombinant-krhn, 10 iu HCPCS Code Code
- J7175 Injection, factor x, (human), 1 i.u. HCPCS Code Code
- J7177 Injection, human fibrinogen concentrate (fibryga), 1 mg HCPCS Code Code
- J7178 Injection, human fibrinogen concentrate, 1 mg HCPCS Code Code
- J7179 Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco HCPCS Code Code
- J7180 Injection, factor xiii (antihemophilic factor, human), 1 HCPCS Code Code
- J7181 Injection, factor xiii a-subunit, (recombinant), per iu HCPCS Code Code
- J7182 Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), HCPCS Code Code
- J7183 Injection, von willebrand factor complex (human), wilate, HCPCS Code Code
- J7184 Injection, von willebrand factor complex (human), wilate, HCPCS Code Code
- J7185 Xyntha inj HCPCS Code Code
- J7186 INJECTION, ANTIHEMOPHILIC FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX HCPCS Code Code
- J7187 injection von willebrand factor complex human HCPCS Code Code
- J7188 INJ VONWILLEBRAND FACTOR IU HCPCS Code Code
- J7189 factor viia antihemophilic factor recombinant per HCPCS Code Code
- J7190 factor viii antihemophilic factor human per HCPCS Code Code
- J7191 factor viii antihemophilic factor porcine per HCPCS Code Code
- J7192 factor viii antihemophilic factor recombinant per HCPCS Code Code
- J7193 factor ix antihemophilic factor purified nonrecombinant HCPCS Code Code
- J7194 factor ix complex per iu HCPCS Code Code
- J7195 factor ix antihemophilic factor recombinant per HCPCS Code Code
- J7196 Injection, antithrombin recombinant, 50 i.u. HCPCS Code Code
- J7197 antithrombin iii human per iu HCPCS Code Code
- J7198 antiinhibitor per iu HCPCS Code Code
- J7199 hemophilia clotting factor not otherwise classified HCPCS Code Code
- J7200 Injection, factor ix, (antihemophilic factor, recombinant), rixubis, HCPCS Code Code
- J7201 Injection, factor ix, fc fusion protein (recombinant), HCPCS Code Code
- J7202 Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u. HCPCS Code Code
- J7203 Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu HCPCS Code Code
- J7204 Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu HCPCS Code Code
- J7205 Injection, factor viii fc fusion protein (recombinant), HCPCS Code Code
- J7207 Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u. HCPCS Code Code
- J7208 Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u. HCPCS Code Code
- J7209 Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u. HCPCS Code Code
- J7210 Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u. HCPCS Code Code
- J7211 Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u. HCPCS Code Code
- J7212 Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram HCPCS Code Code
- J7213 Injection, coagulation factor ix (recombinant), ixinity, 1 i.u. HCPCS Code Code
- J7214 Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u. HCPCS Code Code
- J7294 Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each HCPCS Code Code
- J7295 Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each HCPCS Code Code
- J7296 Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg HCPCS Code Code
- J7297 Levonorgestrel-releasing intrauterine contraceptive system, 52mg, 3 year HCPCS Code Code
- J7298 Levonorgestrel-releasing intrauterine contraceptive system, 52 mg, 5 HCPCS Code Code
- J7300 intrauterine copper contraceptive HCPCS Code Code
- J7301 Levonorgestrel-releasing intrauterine contraceptive system, 13.5 mg HCPCS Code Code
- J7302 levonorgestrelreleasing intrauterine contraceptive system 52 mg HCPCS Code Code
- J7303 contraceptive supply hormone containing vaginal ring HCPCS Code Code
- J7304 contraceptive supply hormone containing patch each HCPCS Code Code
- J7306 levonorgestrel contraceptive implant system including implants HCPCS Code Code
- J7307 ETONOGESTREL IMPLANT SYSTEM HCPCS Code Code
- J7308 aminolevulinic acid hcl topical administration 20 HCPCS Code Code
- J7309 Methyl aminolevulinate (mal) for topical administration, 16.8%, HCPCS Code Code
- J7310 ganciclovir 45 mg longacting implant HCPCS Code Code
- J7311 fluocinolone acetonide intravitreal implant HCPCS Code Code
- J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg HCPCS Code Code
- J7313 Injection, fluocinolone acetonide, intravitreal implant, 0.01 mg HCPCS Code Code
- J7314 Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg HCPCS Code Code
- J7315 Mitomycin, ophthalmic, 0.2 mg HCPCS Code Code
- J7316 Injection, ocriplasmin, 0.125 mg HCPCS Code Code
- J7317 SODIUM HYALURONATE INJECTION HCPCS Code Code
- J7318 Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg HCPCS Code Code
- J7319 hyaluronan sodium hyaluronate derivative intraarticular injection HCPCS Code Code
- J7320 HYLAN G-F 20 INJECTION HCPCS Code Code
- J7321 HYALGAN/SUPARTZ INJ PER DOSE HCPCS Code Code
- J7322 SYNVISC INJ PER DOSE HCPCS Code Code
- J7323 EUFLEXXA INJ PER DOSE HCPCS Code Code
- J7324 ORTHOVISC INJ PER DOSE HCPCS Code Code
- J7325 Synvisc or Synvisc-One HCPCS Code Code
- J7326 Hyaluronan or derivative, gel-one, for intra-articular injection, HCPCS Code Code
- J7327 Hyaluronan or derivative, monovisc, for intra-articular injection, HCPCS Code Code
- J7328 Hyaluronan or derivative, gel-syn, for intra-articular injection, HCPCS Code Code
- J7329 Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg HCPCS Code Code
- J7330 autologous cultured chondrocytes implant HCPCS Code Code
- J7331 Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg HCPCS Code Code
- J7332 Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg HCPCS Code Code
- J7333 Hyaluronan or derivative, visco-3, for intra-articular injection, per dose HCPCS Code Code
- J7335 Capsaicin 8% patch, per 10 square centimeters HCPCS Code Code
- J7336 Capsaicin 8% patch, per square centimeter HCPCS Code Code
- J7340 dermal epidermal substitute tissue human origin HCPCS Code Code
- J7341 dermal substitute tissue nonhuman origin bioengineered HCPCS Code Code
- J7342 dermal substitute tissue human origin bioengineered HCPCS Code Code
- J7343 dermal epidermal substitute tissue nonhuman origin HCPCS Code Code
- J7344 dermal substitute tissue human origin bioengineered HCPCS Code Code
- J7345 dermal substitute tissue nonhuman origin bioengineered HCPCS Code Code
- J7346 dermal substitute tissue human origin injectable HCPCS Code Code
- J7347 INTEGRA MATRIX TISSUE HCPCS Code Code
- J7348 TISSUEMEND TISSUE HCPCS Code Code
- J7349 PRIMATRIX TISSUE HCPCS Code Code
- J7350 INJECTABLE HUMAN TISSUE HCPCS Code Code
- J7351 Injection, bimatoprost, intracameral implant, 1 microgram HCPCS Code Code
- J7352 Afamelanotide implant, 1 mg HCPCS Code Code
- J7353 Anacaulase-bcdb, 8.8% gel, 1 gram HCPCS Code Code
- J7354 Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg) HCPCS Code Code
- J7355 Injection, travoprost, intracameral implant, 1 microgram HCPCS Code Code
- J7401 Mometasone furoate sinus implant, 10 micrograms HCPCS Code Code
- J7402 Mometasone furoate sinus implant, (sinuva), 10 micrograms HCPCS Code Code
- J7500 azathioprine oral 50 mg HCPCS Code Code
- J7501 azathioprine parenteral 100 mg HCPCS Code Code
- J7502 cyclosporine oral 100 mg HCPCS Code Code
- J7503 Tacrolimus, extended release, (envarsus xr), oral, 0.25 HCPCS Code Code
- J7504 lymphocyte immune globulin antithymocyte globulin equine HCPCS Code Code
- J7505 muromonabcd3 parenteral 5 mg HCPCS Code Code
- J7506 prednisone oral per 5mg HCPCS Code Code
- J7507 tacrolimus oral per 1 mg HCPCS Code Code
- J7508 Tacrolimus, extended release, (astagraf xl), oral, 0.1 HCPCS Code Code
- J7509 methylprednisolone oral per 4 mg HCPCS Code Code
- J7510 prednisolone oral per 5 mg HCPCS Code Code
- J7511 lymphocyte immune globulin antithymocyte globulin rabbit HCPCS Code Code
- J7512 Prednisone, immediate release or delayed release, oral, HCPCS Code Code
- J7513 daclizumab parenteral 25 mg HCPCS Code Code
- J7515 cyclosporine oral 25 mg HCPCS Code Code
- J7516 cyclosporin parenteral 250 mg HCPCS Code Code
- J7517 mycophenolate mofetil oral 250 mg HCPCS Code Code
- J7518 mycophenolic acid oral 180 mg HCPCS Code Code
- J7519 Injection, mycophenolate mofetil, 10 mg HCPCS Code Code
- J7520 sirolimus oral 1 mg HCPCS Code Code
- J7525 tacrolimus parenteral 5 mg HCPCS Code Code
- J7527 Everolimus, oral, 0.25 mg HCPCS Code Code
- J7599 immunosuppressive drug not otherwise classified HCPCS Code Code
- J7602 ALBUTEROL INH NON-COMP CON HCPCS Code Code
- J7603 ALBUTEROL INH NON-COMP U D HCPCS Code Code
- J7604 ACETYLCYSTEINE COMP UNIT HCPCS Code Code
- J7605 ARFORMOTEROL NON-COMP UNIT HCPCS Code Code
- J7606 FORMOTEROL FUMARATE, INHALATION SOLUTION, FDA APPROVED FINAL HCPCS Code Code
- J7607 levalbuterol inhalation solution compounded product administered HCPCS Code Code
- J7608 acetylcysteine inhalation solution administered through dme HCPCS Code Code
- J7609 albuterol inhalation solution compounded product administered HCPCS Code Code
- J7610 albuterol inhalation solution compounded product administered HCPCS Code Code
- J7611 albuterol inhalation solution fdaapproved final product HCPCS Code Code
- J7612 levalbuterol inhalation solution fdaapproved final product HCPCS Code Code
- J7613 albuterol inhalation solution fdaapproved final product HCPCS Code Code
- J7614 levalbuterol inhalation solution fdaapproved final product HCPCS Code Code
- J7615 levalbuterol inhalation solution compounded product administered HCPCS Code Code
- J7616 ALBUTEROL COMPOUND SOLUTION HCPCS Code Code
- J7617 LEVALBUTEROL COMPOUNDED SOL HCPCS Code Code
- J7618 ALBUTEROL INH SOL CON HCPCS Code Code
- J7619 ALBUTEROL INH SOL U D HCPCS Code Code
- J7620 albuterol up 25 mg ipratropium bromide HCPCS Code Code
- J7621 (LEVO)ALBUTEROL/IPRA-BROMIDE HCPCS Code Code
- J7622 beclomethasone inhalation solution compounded product HCPCS Code Code
- J7624 betamethasone inhalation solution compounded product administered HCPCS Code Code
- J7626 budesonide inhalation solution fdaapproved final product HCPCS Code Code
- J7627 budesonide inhalation solution compounded product administered HCPCS Code Code
- J7628 bitolterol mesylate inhalation solution compounded product HCPCS Code Code
- J7629 bitolterol mesylate inhalation solution compounded product HCPCS Code Code
- J7631 cromolyn sodium inhalation solution administered through HCPCS Code Code
- J7632 CROMOLYN SODIUM COMP UNIT HCPCS Code Code
- J7633 budesonide inhalation solution fdaapproved final product HCPCS Code Code
- J7634 budesonide inhalation solution compounded product administered HCPCS Code Code
- J7635 atropine inhalation solution compounded product administered HCPCS Code Code
- J7636 atropine inhalation solution compounded product administered HCPCS Code Code
- J7637 dexamethasone inhalation solution compounded product administered HCPCS Code Code
- J7638 dexamethasone inhalation solution compounded product administered HCPCS Code Code
- J7639 dornase alpha inhalation solution administered through HCPCS Code Code
- J7640 formoterol inhalation solution compounded product administered HCPCS Code Code
- J7641 flunisolide inhalation solution compounded product administered HCPCS Code Code
- J7642 glycopyrrolate inhalation solution compounded product administered HCPCS Code Code
- J7643 glycopyrrolate inhalation solution compounded product administered HCPCS Code Code
- J7644 ipratropium bromide inhalation solution fdaapproved final HCPCS Code Code
- J7645 ipratropium bromide inhalation solution compounded product HCPCS Code Code
- J7647 isoetharine hcl inhalation solution compounded product HCPCS Code Code
- J7648 isoetharine hcl inhalation solution fdaapproved final HCPCS Code Code
- J7649 isoetharine hcl inhalation solution fdaapproved final HCPCS Code Code
- J7650 isoetharine hcl inhalation solution compounded product HCPCS Code Code
- J7657 isoproterenol hcl inhalation solution compounded product HCPCS Code Code
- J7658 isoproterenol hcl inhalation solution fdaapproved final HCPCS Code Code
- J7659 isoproterenol hcl inhalation solution fdaapproved final HCPCS Code Code
- J7660 isoproterenol hcl inhalation solution compounded product HCPCS Code Code
- J7665 Mannitol, administered through an inhaler, 5 mg HCPCS Code Code
- J7667 metaproterenol sulfate inhalation solution compounded product HCPCS Code Code
- J7668 metaproterenol sulfate inhalation solution fdaapproved final HCPCS Code Code
- J7669 metaproterenol sulfate inhalation solution fdaapproved final HCPCS Code Code
- J7670 metaproterenol sulfate inhalation solution compounded product HCPCS Code Code
- J7674 methacholine chloride administered as inhalation solution HCPCS Code Code
- J7676 PENTAMIDINE COMP UNIT DOSE HCPCS Code Code
- J7677 Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through DME, 1 microgram HCPCS Code Code
- J7680 terbutaline sulfate inhalation solution compounded product HCPCS Code Code
- J7681 terbutaline sulfate inhalation solution compounded product HCPCS Code Code
- J7682 tobramycin inhalation solution fdaapproved final product HCPCS Code Code
- J7683 triamcinolone inhalation solution compounded product administered HCPCS Code Code
- J7684 triamcinolone inhalation solution compounded product administered HCPCS Code Code
- J7685 tobramycin inhalation solution compounded product administered HCPCS Code Code
- J7686 Treprostinil, inhalation solution, fda-approved final product, non-compounded, HCPCS Code Code
- J7699 noc drugs inhalation solution administered through HCPCS Code Code
- J7799 noc drugs than inhalation drugs administered HCPCS Code Code
- J7999 Compounded drug, not otherwise classified HCPCS Code Code
Back to list of HCPCS Procedure, Supply & DME Codes
HCPCS Medical Codes & Code Modifiers
(HCPCS is commonly pronounced Hick-Picks.)Each year, in the United States, health care insurers process over 5 billion claims for payment. For Medicare and other health insurance programs to ensure that these claims are processed in an orderly and consistent manner, standardized coding systems are essential. The HCPCS Level II Code Set is one of the standard code sets used for this purpose. The HCPCS is divided into two principal subsystems, referred to as level I and level II of the HCPCS. Level I of the HCPCS is comprised of CPT (Current Procedural Terminology), a numeric coding system maintained by the American Medical Association (AMA). The CPT is a uniform coding system consisting of descriptive terms and identifying codes that are used primarily to identify medical services and procedures furnished by physicians and other health care professionals. These health care professionals use the CPT to identify services and procedures for which they bill public or private health insurance programs. Decisions regarding the addition, deletion, or revision of CPT codes are made by the AMA. The CPT codes are republished and updated annually by the AMA. Level I of the HCPCS, the CPT codes, does not include codes needed to separately report medical items or services that are regularly billed by suppliers other than physicians.
Level II of the HCPCS is a standardized coding system that is used primarily to identify products, supplies, and services not included in the CPT codes, such as ambulance services and durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) when used outside a physician's office. Because Medicare and other insurers cover a variety of services, supplies, and equipment that are not identified by CPT codes, the level II HCPCS codes were established for submitting claims for these items. The development and use of level II of the HCPCS began in the 1980's. Level II codes are also referred to as alpha-numeric codes because they consist of a single alphabetical letter followed by 4 numeric digits, while CPT codes are identified using 5 numeric digits.
In October of 2003, the Secretary of HHS delegated authority under the HIPAA legislation to CMS to maintain and distribute HCPCS Level II Codes. As stated in 42 CFR Sec. 414.40 (a) CMS establishes uniform national definitions of services, codes to represent services, and payment modifiers to the codes. Within CMS there is a CMS HCPCS Workgroup which is an internal workgroup comprised of representatives of the major components of CMS, as well as other consultants from pertinent Federal agencies. Prior to December 31, 2003, Level III HCPCS were developed and used by Medicaid State agencies, Medicare contractors, and private insurers in their specific programs or local areas of jurisdiction. For purposes of Medicare, level III codes were also referred to as local codes. Local codes were established when an insurer preferred that suppliers use a local code to identify a service, for which there is no level I or level II code, rather than use a "miscellaneous or not otherwise classified code." The Health Insurance Portability and Accountability Act of 1996 (HIPAA) required CMS to adopt standards for coding systems that are used for reporting health care transactions. We published, in the Federal Register on August 17, 2000 (65 FR 50312), regulations to implement this part of the HIPAA legislation. These regulations provided for the elimination of level III local codes by October 2002, at which time, the level I and level II code sets could be used. The elimination of local codes was postponed, as a result of section 532(a) of BIPA, which continued the use of local codes through December 31, 2003.
(Source: http://www.cms.hhs.gov/MedHCPCSGenInfo/)
Thank you for choosing Find-A-Code, please Sign In to remove ads.